Literature DB >> 25597356

Role of Raf kinase inhibitor protein in Helicobacter pylori-mediated signaling in gastric cancer.

Liana Nisimova1, Sicheng Wen1, Sam Cross-Knorr1, Arlin B Rogers2, Steven F Moss1, Devasis Chatterjee1.   

Abstract

Helicobacter pylori is a helical bacterium that colonizes the stomach in over half of the world's population. Infection with this bacterium has been linked to peptic ulcer disease and gastric cancer. The bacterium has been shown to affect regulatory pathways in its host cells through specific virulence factors that control gene expression. Infection with H. pylori increases levels of phosphorylation of Raf kinase inhibitor protein (pRKIP) in gastric adenocarcinoma (AGS) cells in vitro and in vivo. We investigated the role of H. pylori in the phosphorylation of RKIP as a possible mechanism to downregulate pro-survival signals in gastric adenocarcinoma. pRKIP induces RKIP transcriptional activity, which serves to induce apoptosis of damaged cells to prevent further tumorigenesis. Infection of wild type and RKIP knockout mice with H. pylori for 2 months further confirmed roles of RKIP and pRKIP in the prevention of gastric cancer progression. Loss of RKIP in AGS cells results in increased expression of the Cag A virulence factor after H. pylori infection and RKIP overexpression inhibits H. pylori-mediated STAT3 phosphorylation and STAT3 and NF-κB transcriptional activity. We examined the role of mTOR (mammalian target of rapamycin) after H. pylori infection on the phosphorylation of RKIP. Cells treated with rapamycin, an inhibitor of mTOR, displayed less expression of pRKIP after H. pylori infection. Microarray antibody analysis was conducted on wild-type and RKIP-knockdown AGS cells and showed that in the absence of RKIP, there was increased expression of pro-tumorigenic proteins such as EGFR, Raf-1, and MAPKs. Although further work is needed to confirm the interaction of RKIP and mTOR in AGS cells as a result of H. pylori infection, we hypothesize that H. pylori-mediated induction of pro-survival signaling in gastric epithelial cells induces a feedback response through the activation of RKIP. The phosphorylated, or active, form of RKIP is important in protecting gastric epithelial cells from tumorigenesis after H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25597356      PMCID: PMC5755693          DOI: 10.1615/critrevoncog.2014012044

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  33 in total

1.  Binding of Gbetagamma subunits to cRaf1 downregulates G-protein-coupled receptor signalling.

Authors:  J R Slupsky; U Quitterer; C K Weber; P Gierschik; M J Lohse; U R Rapp
Journal:  Curr Biol       Date:  1999-09-09       Impact factor: 10.834

Review 2.  ErbB receptors: from oncogenes to targeted cancer therapies.

Authors:  Hongtao Zhang; Alan Berezov; Qiang Wang; Geng Zhang; Jeffrey Drebin; Ramachandran Murali; Mark I Greene
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells.

Authors:  Jinxiong Wei; Toni A Nagy; Anna Vilgelm; Elena Zaika; Seth R Ogden; Judith Romero-Gallo; Maria B Piazuelo; Pelayo Correa; Mary K Washington; Wael El-Rifai; Richard M Peek; Alexander Zaika
Journal:  Gastroenterology       Date:  2010-06-12       Impact factor: 22.682

4.  Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.

Authors:  K C Yeung; D W Rose; A S Dhillon; D Yaros; M Gustafsson; D Chatterjee; B McFerran; J Wyche; W Kolch; J M Sedivy
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

5.  Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis.

Authors:  S Huber; C J Bruns; G Schmid; P C Hermann; C Conrad; H Niess; R Huss; C Graeb; K-W Jauch; C Heeschen; M Guba
Journal:  Kidney Int       Date:  2007-02-14       Impact factor: 10.612

6.  Accelerated progression of gastritis to dysplasia in the pyloric antrum of TFF2 -/- C57BL6 x Sv129 Helicobacter pylori-infected mice.

Authors:  James G Fox; Arlin B Rogers; Mark T Whary; Zhongming Ge; Masa Ohtani; Evelyn Kurt Jones; Timothy C Wang
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

7.  RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis.

Authors:  Devasis Chatterjee; Yin Bai; Zhe Wang; Sandy Beach; Stephanie Mott; Rajat Roy; Corey Braastad; Yaping Sun; Asok Mukhopadhyay; Bharat B Aggarwal; James Darnowski; Panayotis Pantazis; James Wyche; Zheng Fu; Yasuhide Kitagwa; Evan T Keller; John M Sedivy; Kam C Yeung
Journal:  J Biol Chem       Date:  2004-02-06       Impact factor: 5.157

Review 8.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

Review 9.  Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene.

Authors:  Evan T Keller; Zheng Fu; Kam Yeung; Meghan Brennan
Journal:  Cancer Lett       Date:  2004-04-30       Impact factor: 8.679

10.  Regulation of RKIP function by Helicobacter pylori in gastric cancer.

Authors:  Erika L Moen; Sicheng Wen; Talha Anwar; Sam Cross-Knorr; Kate Brilliant; Faith Birnbaum; Sherida Rahaman; John M Sedivy; Steven F Moss; Devasis Chatterjee
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

View more
  4 in total

Review 1.  Pathogenesis of Helicobacter pylori Infection.

Authors:  Dionyssios N Sgouras; Tran Thi Huyen Trang; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2015-09       Impact factor: 5.753

2.  Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.

Authors:  Hae Sook Noh; Young-Sool Hah; Ji Hye Ha; Min Young Kang; Sahib Zada; Sun Young Rha; Sang Soo Kang; Hyun Joon Kim; Jae-Yong Park; June-Ho Byun; Jong Ryeal Hahm; Jeong Kyu Shin; Sang-Ho Jeong; Young-Joon Lee; Deok Ryong Kim
Journal:  Oncotarget       Date:  2016-01-26

Review 3.  RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact.

Authors:  Apostolos Zaravinos; Benjamin Bonavida; Ekaterini Chatzaki; Stavroula Baritaki
Journal:  Cancers (Basel)       Date:  2018-08-24       Impact factor: 6.639

Review 4.  RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity.

Authors:  Roni Touboul; Stavroula Baritaki; Apostolos Zaravinos; Benjamin Bonavida
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.